This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Standalone half-year results approved for six months ended 30 September 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.6 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Standalone results for the six months ended 30 September 2026 were approved; no consolidated or latest-quarter figures were provided. Net cash from operating activities was positive at Rs 1,070 lakh, compared with Rs 2,068 lakh for the year ended 31 March 2026. The statutory auditor's review found no material misstatement. No exceptional items were reported, and comparative cash-flow figures were rearranged and reclassified.
Positive operating cash flow and a clean review are supportive, but the lack of quarterly figures and restated comparative cash-flow presentation limits assessment.
| Q2 FY27 | Year ago | Change | |
|---|---|---|---|
| Revenue | ₹51.88 Cr | — | — |
| Operating profit | ₹11.11 Cr | — | — |
| Profit after tax | ₹7.78 Cr | — | — |
| EBITDA margin | 29.4% | — | — |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income. No year-ago figures on this basis yet, so no comparison.